KAYTLIN WRIGHT: Open Payments
NPI 1174147763 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 93 payments from 22 companies in 2025. Trend: 2023 $1,497 · 2024 $1,170 · 2025 $1,814
Food & beverage: $1,797Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $370 |
| Lilly USA, LLC | 13 | $279 |
| ABBVIE INC. | 11 | $175 |
| PFIZER INC. | 10 | $171 |
| Amgen Inc. | 9 | $138 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| Exact Sciences Corporation | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Abbott Laboratories | 2 | $42 |
Products named: MOUNJARO, Ozempic, Auvelity, TRELEGY ELLIPTA, PREVNAR 20, QULIPTA, Cologuard Collection Kit, Rybelsus.
Industry payments across PA — which companies pay providers there.
